Literature DB >> 23278430

A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.

G Warden1, D Harnett, J Green, T Wish, M O Woods, R Green, E Dicks, P Rahman, G Zhai, P Parfrey.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) may be the result of Lynch syndrome (LS) caused by mutations in mismatch repair (MMR) genes, a syndrome of unknown etiology called familial colorectal cancer type-X (FCCTX), or familial serrated neoplasia associated with the colorectal cancer (CRC) somatic BRAF mutation. To determine the cause of HNPCC in the founder population of the island of Newfoundland, we studied 37 families with LS and 29 families without LS who fulfilled the Amsterdam I criteria. In non-LS, four index CRCs were BRAF mutation positive, one of which was microsatellite instable. Geographic clustering of LS families caused by three different founder mutations in MSH2 was observed. Nine unique MMR mutations in four MMR genes were identified in single families distributed in different geographic isolates. The geographic distribution of non-LS was similar to LS. The coefficient of relatedness using genotype data was significantly higher for non-LS than for all CRC. Extensive genealogic investigation failed to connect non-LS families and in some clusters pathologic CRC heterogeneity was observed. We conclude that non-LS HNPCC may be a heterogeneous disorder with different pathogenic pathways, and that the geographic distribution is consistent with multiple different mutations in unknown CRC susceptibility gene(s).
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BRAF; Lynch syndrome; familial colorectal cancer type-X; hereditary non-polyposis colorectal cancer; population-based study

Mesh:

Substances:

Year:  2013        PMID: 23278430     DOI: 10.1111/cge.12080

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

1.  Genetic structure of the Newfoundland and Labrador population: founder effects modulate variability.

Authors:  Guangju Zhai; Jiayi Zhou; Michael O Woods; Jane S Green; Patrick Parfrey; Proton Rahman; Roger C Green
Journal:  Eur J Hum Genet       Date:  2015-12-16       Impact factor: 4.246

2.  Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland.

Authors:  Daniel R Evans; Jane S Green; Michael O Woods
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

3.  Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees.

Authors:  Yun Xu; Cong Li; Yuqin Zhang; Tian'an Guo; Congcong Zhu; Ye Xu; Fangqi Liu
Journal:  Front Oncol       Date:  2020-09-02       Impact factor: 6.244

4.  First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.

Authors:  H Ziada-Bouchaar; K Sifi; T Filali; T Hammada; D Satta; N Abadi
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 5.  Familial Colorectal Cancer Type X.

Authors:  Diana Bregner Zetner; Marie Luise Bisgaard
Journal:  Curr Genomics       Date:  2017-08       Impact factor: 2.236

6.  Evaluation of a population-based approach to familial colorectal cancer.

Authors:  P S Parfrey; E Dicks; O Parfrey; P J McNicholas; H Noseworthy; M O Woods; C Negriin; J Green
Journal:  Clin Genet       Date:  2017-03-08       Impact factor: 4.438

7.  Impact of colonoscopic screening in Familial Colorectal Cancer Type X.

Authors:  Elizabeth Hatfield; Jane S Green; Michael O Woods; Geoff Warden; Patrick S Parfrey
Journal:  Mol Genet Genomic Med       Date:  2018-10-09       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.